fluorodeoxyglucose f18 has been researched along with idazoxan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, RM; Matochik, JA; Potter, WZ; Risinger, RC; Schmidt, ME; Schouten, JL; Zametkin, AJ | 1 |
| Goldstein, DS; Matochik, JA; Potter, WZ; Schmidt, ME; Schouten, JL; Zametkin, AJ | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and idazoxan
| Article | Year |
|---|---|
Gender differences in brain metabolic and plasma catecholamine responses to alpha 2-adrenoceptor blockade.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Brain Chemistry; Catecholamines; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Heart Rate; Humans; Idazoxan; Male; Sex Characteristics; Tomography, Emission-Computed | 1997 |
1 other study(ies) available for fluorodeoxyglucose f18 and idazoxan
| Article | Year |
|---|---|
Regional brain glucose metabolism after acute alpha 2-blockade by idazoxan.
Topics: Adrenergic alpha-Antagonists; Adult; Affect; Analysis of Variance; Brain; Deoxyglucose; Dioxanes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Idazoxan; Male; Reference Values; Tomography, Emission-Computed | 1995 |